The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended 5-y follow-up (FU) of phase 3 ELOQUENT-2 study of elotuzumab + lenalidomide/dexamethasone (ELd) vs Ld in relapsed/refractory multiple myeloma (RRMM).
 
Sagar Lonial
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Millennium; Novartis; Onyx
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen (Inst); Celgene (Inst); Janssen (Inst); Sanofi (Inst)
 
Darrell White
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Takeda (Inst)
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
 
Jesus San-Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; MSD; Novartis; Roche; Sanofi; Takeda
 
Kenneth Carl Anderson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Millennium
Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep
 
Ofer Shpilberg
Consulting or Advisory Role - Gilead Sciences; Millennium
 
Sebastian Grosicki
No Relationships to Disclose
 
Ivan Spicka
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen (Inst); Celgene (Inst)
 
Adam Walter-Croneck
Consulting or Advisory Role - Janssen
 
Hila Magen
No Relationships to Disclose
 
Andrew Belch
No Relationships to Disclose
 
Donna Ellen Reece
Honoraria - Amgen; Celgene; Janssen; Merck; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Merck; Takeda
Speakers' Bureau - Celgene; Janssen; Merck; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Otsuka; Takeda
Expert Testimony - Amgen; Janssen
 
Meral Beksac
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Novartis (Inst); Takeda (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Suresh Shelat
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Oumar Sy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Anil K. Singhal
Employment - Abbvie
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Takeda
Research Funding - Celgene; Takeda